Helena Harder
@drhelenaharder.bsky.social
Principal Research Fellow at SHORE-C, Brighton and Sussex Medical School, UK. All views are my own. https://shore-c.sussex.ac.uk/
With generative AI tools improving so rapidly, attitudes about using them to write research papers are also evolving https://go.nature.com/439RfZL
Is it OK for AI to write science papers? Nature survey shows researchers are split
Poll of 5,000 researchers finds contrasting views on when it’s acceptable to involve AI and what needs to be disclosed.
go.nature.com
First research papers on patients' experiences of abemaciclib and ET for advanced or metastatic #breastcancer. Diarrhoea is a real concern.
SHORE-C@shore-c.bsky.social · last yr.SHORE-C have two papers in the new edition of Springer's Supportive Care in Cancer journal! Congratulations to the authors @drhelenaharder.bsky.social, Rachel Starkings, @lfallowfield.bsky.social, Valerie Shilling and Shirley May. doi.org/10.1007/s005... doi.org/10.1007/s005...
SHORE-C have two papers in the new edition of Springer's Supportive Care in Cancer journal! Congratulations to the authors @drhelenaharder.bsky.social, Rachel Starkings, @lfallowfield.bsky.social, Valerie Shilling and Shirley May. doi.org/10.1007/s005... doi.org/10.1007/s005...
Incidence and management of diarrhoea associated with abemaciclib and endocrine therapy for hormone-receptor positive, HER2-negative metastatic breast cancer: the UK patients’ experiences - Supportive...
Purpose Addition of a CDK4/6 inhibitor to endocrine therapy (ET) prolongs survival in HR + /HER2-metastatic breast cancer (MBC). Gastrointestinal side effects, predominantly diarrhoea and abdominal pa...
doi.org
SHORE-C is happy to join BlueSky. For more information about us and our research, see our website - shore-c.sussex.ac.uk
SHORE-C
shore-c.sussex.ac.uk